home / stock / rdy / rdy news


RDY News and Press, Dr. Reddy's Laboratories Ltd From 01/29/24

Stock Information

Company Name: Dr. Reddy's Laboratories Ltd
Stock Symbol: RDY
Market: NYSE
Website: drreddys.com

Menu

RDY RDY Quote RDY Short RDY News RDY Articles RDY Message Board
Get RDY Alerts

News, Short Squeeze, Breakout and More Instantly...

RDY - Notable earnings before Tuesday's open

2024-01-29 10:20:56 ET Major earnings expected before the bell on Tuesday include: Corning ( GLW ) General Motors ( GM ) Marathon Petroleum ( MPC ) Pfizer ( PFE ) United Parcel Service ( UPS ) Read the full article on Seeking Alpha For...

RDY - Expected US Company Earnings on Wednesday, January 24th, 2024

FFW Corp. (FFWC) is expected to report for Q2 2024 ResMed Inc. (RMD) is expected to report $1.81 for Q2 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2023-12-31 ChoiceOne Financial Services Inc. (COFS) is expected to report $0.64 for Q4 2023 First ...

RDY - Watch GSK amid hearing on Zantac litigation

2024-01-23 15:00:40 ET More on GSK GSK plc (GSK) 42nd Annual JP Morgan Healthcare Conference (Transcript) AbbVie Vs. GSK: Dual Dominance In Pharma GSK - Greenshoots In The Horizon GSK sells off partial stake in Haleon for $1.2B GSK to sell 3.2% stake ...

RDY - From Euphoria To Reality: Viatris' Tale Of Market Whirlwind

2024-01-12 12:54:48 ET Summary Viatris is an American pharmaceutical company formed as a result of the merger of Mylan and Upjohn. Over the past two and a half months, Viatris' share price has risen by more than 38%. Viatris' dividend yield is 3.97%, which is attractive becaus...

RDY - How to Take Advantage of moves in (RDY)

2024-01-11 01:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

RDY - Journey Medical submits NDA for DFD-29 for rosacea

2024-01-05 09:20:37 ET More on Journey Medical, Dr. Reddy's, etc. The Strategic Evolution Of Journey Medical In Dermatological Care Dr. Reddy's Laboratories: Q2 Earnings Reveals Strong Growth And Promising Advancements Journey Medical Corporation (DERM) Q3 2023 Earni...

RDY - Dr. Reddy's acquires MenoLabs business from Amyris

2024-01-03 06:16:20 ET Dr. Reddy's Laboratories ( NYSE: RDY ) on Wednesday announced a deal to acquire a women's health and dietary supplements portfolio of brands from Amyris ( OTC:AMRSQ ) as part of the latter's Chapter 11 sales process. Terms of the deal were not disc...

RDY - Dr. Reddy's Announces the Acquisition of MenoLabs®, a Leading Women's Health and Dietary Supplements Portfolio of Brands

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced that it has acquired MenoLabs ® business, a leading women’s health and dietary supplement branded portfolio fr...

RDY - Dr. Reddy's acquires 6.46% stake in Israeli biotech Edity Therapeutics

2023-12-29 14:52:48 ET More on Dr. Reddy's Dr. Reddy's Laboratories: Q2 Earnings Reveals Strong Growth And Promising Advancements Dr Reddy's Laboratories Ltd (RDY) Q2 2024 Earnings Call Transcript Dr. Reddy's: Continued Q2 Earnings Growth, Supports Long-Term Investme...

RDY - Trend Tracker for (RDY)

2023-12-24 02:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Previous 10 Next 10